Research ArticleArticle
Systemic Autoimmune Rheumatic Disease Prevalence in Canada: Updated Analyses Across 7 Provinces
Laurel Broten, J. Antonio Aviña-Zubieta, Diane Lacaille, Lawrence Joseph, John G. Hanly, Lisa Lix, Siobhan O’Donnell, Cheryl Barnabe, Paul R. Fortin, Marie Hudson, Sonia Jean, Christine Peschken, Steven M. Edworthy, Larry Svenson, Christian A. Pineau, Ann E. Clarke, Mark Smith, Patrick Bélisle, Elizabeth M. Badley, Louise Bergeron and Sasha Bernatsky
The Journal of Rheumatology March 2014, jrheum.130667; DOI: https://doi.org/10.3899/jrheum.130667
Laurel Broten
From the Division of Clinical Epidemiology, and Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia; Department of Epidemiology and Biostatistics, and Division of Rheumatology, McGill University; Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Departments of Medicine and Community Health Sciences, University of Manitoba, and Repository, Manitoba Centre for Health Policy, Winnipeg, Manitoba; Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario; Division of Rheumatology, University of Calgary, Calgary, Alberta; Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval, Quebec City, Quebec; Chronic Disease Surveillance Division, National Institute of Public Health of Québec; Health Surveillance Branch, Public Health Division, Alberta Health and Wellness, Edmonton, Alberta; Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the MUHC; Canadian Arthritis Patient Alliance; Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada. L. Broten, Student, Division of Clinical Epidemiology, Research Institute of the MUHC; J.A. Aviña-Zubieta, MD, PhD, BC Lupus Society Scholar, Assistant Professor; D. Lacaille, MD, MHSc, Professor, Division of Rheumatology, University of British Columbia; L. Joseph, PhD, Professor, Department of Epidemiology and Biostatistics, McGill University; J.G. Hanly, MD, Professor of Medicine (Rheumatology) and Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center; L. Lix, PhD, Professor, Department of Community Health Sciences, University of Manitoba; S. O’Donnell, MSc, Centre for Chronic Disease Prevention, Public Health Agency of Canada; C. Barnabe, MD, MSc, Assistant Professor, Division of Rheumatology, University of Calgary; P.R. Fortin, MD, MPH, Professor, Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval; M. Hudson, MD, Assistant Professor, Division of Rheumatology, McGill University; S. Jean, PhD, Chronic Disease Surveillance Division, National Institute of Public Health of Québec; C.A. Peschken, MD, MSc, Associate Professor, Departments of Medicine and Community Health Sciences Director, University of Manitoba; S.M. Edworthy, MD, Professor, Division of Rheumatology, University of Calgary; L. Svenson, BSc, Health Surveillance Branch, Public Health Division, Alberta Health and Wellness; C.A. Pineau, MD, Assistant Professor, Division of Rheumatology, Research Institute of the MUHC; A.E. Clarke, MD, MSc, Professor of Medicine, Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Research Institute of the MUHC; M. Smith, MSc, Associate Director, Repository, Manitoba Centre for Health Policy, University of Manitoba; P. Bélisle, MSc, Division of Clinical Epidemiology, Research Institute of the MUHC; E.M. Badley, D.Phil, Professor, Senior Scientist, Toronto Western Research Institute University Health Network; L. Bergeron, Patient advocate, Canadian Arthritis Patient Alliance; S. Bernatsky, MD, PhD, Associate Professor, Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre. Address correspondence to Dr. S. Bernatsky, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre (MUHC), 687 Pine Avenue West, V-Building, V2.09, Montreal, Quebec H3A 1A1, Canada. E-mail: sasha.bernatsky@mcgill.ca. Accepted for publication December 19, 2013.
J. Antonio Aviña-Zubieta
From the Division of Clinical Epidemiology, and Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia; Department of Epidemiology and Biostatistics, and Division of Rheumatology, McGill University; Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Departments of Medicine and Community Health Sciences, University of Manitoba, and Repository, Manitoba Centre for Health Policy, Winnipeg, Manitoba; Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario; Division of Rheumatology, University of Calgary, Calgary, Alberta; Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval, Quebec City, Quebec; Chronic Disease Surveillance Division, National Institute of Public Health of Québec; Health Surveillance Branch, Public Health Division, Alberta Health and Wellness, Edmonton, Alberta; Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the MUHC; Canadian Arthritis Patient Alliance; Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada. L. Broten, Student, Division of Clinical Epidemiology, Research Institute of the MUHC; J.A. Aviña-Zubieta, MD, PhD, BC Lupus Society Scholar, Assistant Professor; D. Lacaille, MD, MHSc, Professor, Division of Rheumatology, University of British Columbia; L. Joseph, PhD, Professor, Department of Epidemiology and Biostatistics, McGill University; J.G. Hanly, MD, Professor of Medicine (Rheumatology) and Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center; L. Lix, PhD, Professor, Department of Community Health Sciences, University of Manitoba; S. O’Donnell, MSc, Centre for Chronic Disease Prevention, Public Health Agency of Canada; C. Barnabe, MD, MSc, Assistant Professor, Division of Rheumatology, University of Calgary; P.R. Fortin, MD, MPH, Professor, Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval; M. Hudson, MD, Assistant Professor, Division of Rheumatology, McGill University; S. Jean, PhD, Chronic Disease Surveillance Division, National Institute of Public Health of Québec; C.A. Peschken, MD, MSc, Associate Professor, Departments of Medicine and Community Health Sciences Director, University of Manitoba; S.M. Edworthy, MD, Professor, Division of Rheumatology, University of Calgary; L. Svenson, BSc, Health Surveillance Branch, Public Health Division, Alberta Health and Wellness; C.A. Pineau, MD, Assistant Professor, Division of Rheumatology, Research Institute of the MUHC; A.E. Clarke, MD, MSc, Professor of Medicine, Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Research Institute of the MUHC; M. Smith, MSc, Associate Director, Repository, Manitoba Centre for Health Policy, University of Manitoba; P. Bélisle, MSc, Division of Clinical Epidemiology, Research Institute of the MUHC; E.M. Badley, D.Phil, Professor, Senior Scientist, Toronto Western Research Institute University Health Network; L. Bergeron, Patient advocate, Canadian Arthritis Patient Alliance; S. Bernatsky, MD, PhD, Associate Professor, Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre. Address correspondence to Dr. S. Bernatsky, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre (MUHC), 687 Pine Avenue West, V-Building, V2.09, Montreal, Quebec H3A 1A1, Canada. E-mail: sasha.bernatsky@mcgill.ca. Accepted for publication December 19, 2013.
Diane Lacaille
From the Division of Clinical Epidemiology, and Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia; Department of Epidemiology and Biostatistics, and Division of Rheumatology, McGill University; Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Departments of Medicine and Community Health Sciences, University of Manitoba, and Repository, Manitoba Centre for Health Policy, Winnipeg, Manitoba; Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario; Division of Rheumatology, University of Calgary, Calgary, Alberta; Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval, Quebec City, Quebec; Chronic Disease Surveillance Division, National Institute of Public Health of Québec; Health Surveillance Branch, Public Health Division, Alberta Health and Wellness, Edmonton, Alberta; Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the MUHC; Canadian Arthritis Patient Alliance; Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada. L. Broten, Student, Division of Clinical Epidemiology, Research Institute of the MUHC; J.A. Aviña-Zubieta, MD, PhD, BC Lupus Society Scholar, Assistant Professor; D. Lacaille, MD, MHSc, Professor, Division of Rheumatology, University of British Columbia; L. Joseph, PhD, Professor, Department of Epidemiology and Biostatistics, McGill University; J.G. Hanly, MD, Professor of Medicine (Rheumatology) and Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center; L. Lix, PhD, Professor, Department of Community Health Sciences, University of Manitoba; S. O’Donnell, MSc, Centre for Chronic Disease Prevention, Public Health Agency of Canada; C. Barnabe, MD, MSc, Assistant Professor, Division of Rheumatology, University of Calgary; P.R. Fortin, MD, MPH, Professor, Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval; M. Hudson, MD, Assistant Professor, Division of Rheumatology, McGill University; S. Jean, PhD, Chronic Disease Surveillance Division, National Institute of Public Health of Québec; C.A. Peschken, MD, MSc, Associate Professor, Departments of Medicine and Community Health Sciences Director, University of Manitoba; S.M. Edworthy, MD, Professor, Division of Rheumatology, University of Calgary; L. Svenson, BSc, Health Surveillance Branch, Public Health Division, Alberta Health and Wellness; C.A. Pineau, MD, Assistant Professor, Division of Rheumatology, Research Institute of the MUHC; A.E. Clarke, MD, MSc, Professor of Medicine, Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Research Institute of the MUHC; M. Smith, MSc, Associate Director, Repository, Manitoba Centre for Health Policy, University of Manitoba; P. Bélisle, MSc, Division of Clinical Epidemiology, Research Institute of the MUHC; E.M. Badley, D.Phil, Professor, Senior Scientist, Toronto Western Research Institute University Health Network; L. Bergeron, Patient advocate, Canadian Arthritis Patient Alliance; S. Bernatsky, MD, PhD, Associate Professor, Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre. Address correspondence to Dr. S. Bernatsky, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre (MUHC), 687 Pine Avenue West, V-Building, V2.09, Montreal, Quebec H3A 1A1, Canada. E-mail: sasha.bernatsky@mcgill.ca. Accepted for publication December 19, 2013.
Lawrence Joseph
From the Division of Clinical Epidemiology, and Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia; Department of Epidemiology and Biostatistics, and Division of Rheumatology, McGill University; Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Departments of Medicine and Community Health Sciences, University of Manitoba, and Repository, Manitoba Centre for Health Policy, Winnipeg, Manitoba; Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario; Division of Rheumatology, University of Calgary, Calgary, Alberta; Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval, Quebec City, Quebec; Chronic Disease Surveillance Division, National Institute of Public Health of Québec; Health Surveillance Branch, Public Health Division, Alberta Health and Wellness, Edmonton, Alberta; Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the MUHC; Canadian Arthritis Patient Alliance; Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada. L. Broten, Student, Division of Clinical Epidemiology, Research Institute of the MUHC; J.A. Aviña-Zubieta, MD, PhD, BC Lupus Society Scholar, Assistant Professor; D. Lacaille, MD, MHSc, Professor, Division of Rheumatology, University of British Columbia; L. Joseph, PhD, Professor, Department of Epidemiology and Biostatistics, McGill University; J.G. Hanly, MD, Professor of Medicine (Rheumatology) and Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center; L. Lix, PhD, Professor, Department of Community Health Sciences, University of Manitoba; S. O’Donnell, MSc, Centre for Chronic Disease Prevention, Public Health Agency of Canada; C. Barnabe, MD, MSc, Assistant Professor, Division of Rheumatology, University of Calgary; P.R. Fortin, MD, MPH, Professor, Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval; M. Hudson, MD, Assistant Professor, Division of Rheumatology, McGill University; S. Jean, PhD, Chronic Disease Surveillance Division, National Institute of Public Health of Québec; C.A. Peschken, MD, MSc, Associate Professor, Departments of Medicine and Community Health Sciences Director, University of Manitoba; S.M. Edworthy, MD, Professor, Division of Rheumatology, University of Calgary; L. Svenson, BSc, Health Surveillance Branch, Public Health Division, Alberta Health and Wellness; C.A. Pineau, MD, Assistant Professor, Division of Rheumatology, Research Institute of the MUHC; A.E. Clarke, MD, MSc, Professor of Medicine, Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Research Institute of the MUHC; M. Smith, MSc, Associate Director, Repository, Manitoba Centre for Health Policy, University of Manitoba; P. Bélisle, MSc, Division of Clinical Epidemiology, Research Institute of the MUHC; E.M. Badley, D.Phil, Professor, Senior Scientist, Toronto Western Research Institute University Health Network; L. Bergeron, Patient advocate, Canadian Arthritis Patient Alliance; S. Bernatsky, MD, PhD, Associate Professor, Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre. Address correspondence to Dr. S. Bernatsky, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre (MUHC), 687 Pine Avenue West, V-Building, V2.09, Montreal, Quebec H3A 1A1, Canada. E-mail: sasha.bernatsky@mcgill.ca. Accepted for publication December 19, 2013.
John G. Hanly
From the Division of Clinical Epidemiology, and Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia; Department of Epidemiology and Biostatistics, and Division of Rheumatology, McGill University; Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Departments of Medicine and Community Health Sciences, University of Manitoba, and Repository, Manitoba Centre for Health Policy, Winnipeg, Manitoba; Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario; Division of Rheumatology, University of Calgary, Calgary, Alberta; Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval, Quebec City, Quebec; Chronic Disease Surveillance Division, National Institute of Public Health of Québec; Health Surveillance Branch, Public Health Division, Alberta Health and Wellness, Edmonton, Alberta; Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the MUHC; Canadian Arthritis Patient Alliance; Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada. L. Broten, Student, Division of Clinical Epidemiology, Research Institute of the MUHC; J.A. Aviña-Zubieta, MD, PhD, BC Lupus Society Scholar, Assistant Professor; D. Lacaille, MD, MHSc, Professor, Division of Rheumatology, University of British Columbia; L. Joseph, PhD, Professor, Department of Epidemiology and Biostatistics, McGill University; J.G. Hanly, MD, Professor of Medicine (Rheumatology) and Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center; L. Lix, PhD, Professor, Department of Community Health Sciences, University of Manitoba; S. O’Donnell, MSc, Centre for Chronic Disease Prevention, Public Health Agency of Canada; C. Barnabe, MD, MSc, Assistant Professor, Division of Rheumatology, University of Calgary; P.R. Fortin, MD, MPH, Professor, Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval; M. Hudson, MD, Assistant Professor, Division of Rheumatology, McGill University; S. Jean, PhD, Chronic Disease Surveillance Division, National Institute of Public Health of Québec; C.A. Peschken, MD, MSc, Associate Professor, Departments of Medicine and Community Health Sciences Director, University of Manitoba; S.M. Edworthy, MD, Professor, Division of Rheumatology, University of Calgary; L. Svenson, BSc, Health Surveillance Branch, Public Health Division, Alberta Health and Wellness; C.A. Pineau, MD, Assistant Professor, Division of Rheumatology, Research Institute of the MUHC; A.E. Clarke, MD, MSc, Professor of Medicine, Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Research Institute of the MUHC; M. Smith, MSc, Associate Director, Repository, Manitoba Centre for Health Policy, University of Manitoba; P. Bélisle, MSc, Division of Clinical Epidemiology, Research Institute of the MUHC; E.M. Badley, D.Phil, Professor, Senior Scientist, Toronto Western Research Institute University Health Network; L. Bergeron, Patient advocate, Canadian Arthritis Patient Alliance; S. Bernatsky, MD, PhD, Associate Professor, Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre. Address correspondence to Dr. S. Bernatsky, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre (MUHC), 687 Pine Avenue West, V-Building, V2.09, Montreal, Quebec H3A 1A1, Canada. E-mail: sasha.bernatsky@mcgill.ca. Accepted for publication December 19, 2013.
Lisa Lix
From the Division of Clinical Epidemiology, and Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia; Department of Epidemiology and Biostatistics, and Division of Rheumatology, McGill University; Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Departments of Medicine and Community Health Sciences, University of Manitoba, and Repository, Manitoba Centre for Health Policy, Winnipeg, Manitoba; Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario; Division of Rheumatology, University of Calgary, Calgary, Alberta; Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval, Quebec City, Quebec; Chronic Disease Surveillance Division, National Institute of Public Health of Québec; Health Surveillance Branch, Public Health Division, Alberta Health and Wellness, Edmonton, Alberta; Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the MUHC; Canadian Arthritis Patient Alliance; Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada. L. Broten, Student, Division of Clinical Epidemiology, Research Institute of the MUHC; J.A. Aviña-Zubieta, MD, PhD, BC Lupus Society Scholar, Assistant Professor; D. Lacaille, MD, MHSc, Professor, Division of Rheumatology, University of British Columbia; L. Joseph, PhD, Professor, Department of Epidemiology and Biostatistics, McGill University; J.G. Hanly, MD, Professor of Medicine (Rheumatology) and Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center; L. Lix, PhD, Professor, Department of Community Health Sciences, University of Manitoba; S. O’Donnell, MSc, Centre for Chronic Disease Prevention, Public Health Agency of Canada; C. Barnabe, MD, MSc, Assistant Professor, Division of Rheumatology, University of Calgary; P.R. Fortin, MD, MPH, Professor, Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval; M. Hudson, MD, Assistant Professor, Division of Rheumatology, McGill University; S. Jean, PhD, Chronic Disease Surveillance Division, National Institute of Public Health of Québec; C.A. Peschken, MD, MSc, Associate Professor, Departments of Medicine and Community Health Sciences Director, University of Manitoba; S.M. Edworthy, MD, Professor, Division of Rheumatology, University of Calgary; L. Svenson, BSc, Health Surveillance Branch, Public Health Division, Alberta Health and Wellness; C.A. Pineau, MD, Assistant Professor, Division of Rheumatology, Research Institute of the MUHC; A.E. Clarke, MD, MSc, Professor of Medicine, Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Research Institute of the MUHC; M. Smith, MSc, Associate Director, Repository, Manitoba Centre for Health Policy, University of Manitoba; P. Bélisle, MSc, Division of Clinical Epidemiology, Research Institute of the MUHC; E.M. Badley, D.Phil, Professor, Senior Scientist, Toronto Western Research Institute University Health Network; L. Bergeron, Patient advocate, Canadian Arthritis Patient Alliance; S. Bernatsky, MD, PhD, Associate Professor, Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre. Address correspondence to Dr. S. Bernatsky, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre (MUHC), 687 Pine Avenue West, V-Building, V2.09, Montreal, Quebec H3A 1A1, Canada. E-mail: sasha.bernatsky@mcgill.ca. Accepted for publication December 19, 2013.
Siobhan O’Donnell
From the Division of Clinical Epidemiology, and Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia; Department of Epidemiology and Biostatistics, and Division of Rheumatology, McGill University; Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Departments of Medicine and Community Health Sciences, University of Manitoba, and Repository, Manitoba Centre for Health Policy, Winnipeg, Manitoba; Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario; Division of Rheumatology, University of Calgary, Calgary, Alberta; Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval, Quebec City, Quebec; Chronic Disease Surveillance Division, National Institute of Public Health of Québec; Health Surveillance Branch, Public Health Division, Alberta Health and Wellness, Edmonton, Alberta; Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the MUHC; Canadian Arthritis Patient Alliance; Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada. L. Broten, Student, Division of Clinical Epidemiology, Research Institute of the MUHC; J.A. Aviña-Zubieta, MD, PhD, BC Lupus Society Scholar, Assistant Professor; D. Lacaille, MD, MHSc, Professor, Division of Rheumatology, University of British Columbia; L. Joseph, PhD, Professor, Department of Epidemiology and Biostatistics, McGill University; J.G. Hanly, MD, Professor of Medicine (Rheumatology) and Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center; L. Lix, PhD, Professor, Department of Community Health Sciences, University of Manitoba; S. O’Donnell, MSc, Centre for Chronic Disease Prevention, Public Health Agency of Canada; C. Barnabe, MD, MSc, Assistant Professor, Division of Rheumatology, University of Calgary; P.R. Fortin, MD, MPH, Professor, Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval; M. Hudson, MD, Assistant Professor, Division of Rheumatology, McGill University; S. Jean, PhD, Chronic Disease Surveillance Division, National Institute of Public Health of Québec; C.A. Peschken, MD, MSc, Associate Professor, Departments of Medicine and Community Health Sciences Director, University of Manitoba; S.M. Edworthy, MD, Professor, Division of Rheumatology, University of Calgary; L. Svenson, BSc, Health Surveillance Branch, Public Health Division, Alberta Health and Wellness; C.A. Pineau, MD, Assistant Professor, Division of Rheumatology, Research Institute of the MUHC; A.E. Clarke, MD, MSc, Professor of Medicine, Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Research Institute of the MUHC; M. Smith, MSc, Associate Director, Repository, Manitoba Centre for Health Policy, University of Manitoba; P. Bélisle, MSc, Division of Clinical Epidemiology, Research Institute of the MUHC; E.M. Badley, D.Phil, Professor, Senior Scientist, Toronto Western Research Institute University Health Network; L. Bergeron, Patient advocate, Canadian Arthritis Patient Alliance; S. Bernatsky, MD, PhD, Associate Professor, Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre. Address correspondence to Dr. S. Bernatsky, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre (MUHC), 687 Pine Avenue West, V-Building, V2.09, Montreal, Quebec H3A 1A1, Canada. E-mail: sasha.bernatsky@mcgill.ca. Accepted for publication December 19, 2013.
Cheryl Barnabe
From the Division of Clinical Epidemiology, and Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia; Department of Epidemiology and Biostatistics, and Division of Rheumatology, McGill University; Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Departments of Medicine and Community Health Sciences, University of Manitoba, and Repository, Manitoba Centre for Health Policy, Winnipeg, Manitoba; Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario; Division of Rheumatology, University of Calgary, Calgary, Alberta; Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval, Quebec City, Quebec; Chronic Disease Surveillance Division, National Institute of Public Health of Québec; Health Surveillance Branch, Public Health Division, Alberta Health and Wellness, Edmonton, Alberta; Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the MUHC; Canadian Arthritis Patient Alliance; Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada. L. Broten, Student, Division of Clinical Epidemiology, Research Institute of the MUHC; J.A. Aviña-Zubieta, MD, PhD, BC Lupus Society Scholar, Assistant Professor; D. Lacaille, MD, MHSc, Professor, Division of Rheumatology, University of British Columbia; L. Joseph, PhD, Professor, Department of Epidemiology and Biostatistics, McGill University; J.G. Hanly, MD, Professor of Medicine (Rheumatology) and Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center; L. Lix, PhD, Professor, Department of Community Health Sciences, University of Manitoba; S. O’Donnell, MSc, Centre for Chronic Disease Prevention, Public Health Agency of Canada; C. Barnabe, MD, MSc, Assistant Professor, Division of Rheumatology, University of Calgary; P.R. Fortin, MD, MPH, Professor, Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval; M. Hudson, MD, Assistant Professor, Division of Rheumatology, McGill University; S. Jean, PhD, Chronic Disease Surveillance Division, National Institute of Public Health of Québec; C.A. Peschken, MD, MSc, Associate Professor, Departments of Medicine and Community Health Sciences Director, University of Manitoba; S.M. Edworthy, MD, Professor, Division of Rheumatology, University of Calgary; L. Svenson, BSc, Health Surveillance Branch, Public Health Division, Alberta Health and Wellness; C.A. Pineau, MD, Assistant Professor, Division of Rheumatology, Research Institute of the MUHC; A.E. Clarke, MD, MSc, Professor of Medicine, Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Research Institute of the MUHC; M. Smith, MSc, Associate Director, Repository, Manitoba Centre for Health Policy, University of Manitoba; P. Bélisle, MSc, Division of Clinical Epidemiology, Research Institute of the MUHC; E.M. Badley, D.Phil, Professor, Senior Scientist, Toronto Western Research Institute University Health Network; L. Bergeron, Patient advocate, Canadian Arthritis Patient Alliance; S. Bernatsky, MD, PhD, Associate Professor, Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre. Address correspondence to Dr. S. Bernatsky, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre (MUHC), 687 Pine Avenue West, V-Building, V2.09, Montreal, Quebec H3A 1A1, Canada. E-mail: sasha.bernatsky@mcgill.ca. Accepted for publication December 19, 2013.
Paul R. Fortin
From the Division of Clinical Epidemiology, and Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia; Department of Epidemiology and Biostatistics, and Division of Rheumatology, McGill University; Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Departments of Medicine and Community Health Sciences, University of Manitoba, and Repository, Manitoba Centre for Health Policy, Winnipeg, Manitoba; Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario; Division of Rheumatology, University of Calgary, Calgary, Alberta; Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval, Quebec City, Quebec; Chronic Disease Surveillance Division, National Institute of Public Health of Québec; Health Surveillance Branch, Public Health Division, Alberta Health and Wellness, Edmonton, Alberta; Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the MUHC; Canadian Arthritis Patient Alliance; Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada. L. Broten, Student, Division of Clinical Epidemiology, Research Institute of the MUHC; J.A. Aviña-Zubieta, MD, PhD, BC Lupus Society Scholar, Assistant Professor; D. Lacaille, MD, MHSc, Professor, Division of Rheumatology, University of British Columbia; L. Joseph, PhD, Professor, Department of Epidemiology and Biostatistics, McGill University; J.G. Hanly, MD, Professor of Medicine (Rheumatology) and Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center; L. Lix, PhD, Professor, Department of Community Health Sciences, University of Manitoba; S. O’Donnell, MSc, Centre for Chronic Disease Prevention, Public Health Agency of Canada; C. Barnabe, MD, MSc, Assistant Professor, Division of Rheumatology, University of Calgary; P.R. Fortin, MD, MPH, Professor, Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval; M. Hudson, MD, Assistant Professor, Division of Rheumatology, McGill University; S. Jean, PhD, Chronic Disease Surveillance Division, National Institute of Public Health of Québec; C.A. Peschken, MD, MSc, Associate Professor, Departments of Medicine and Community Health Sciences Director, University of Manitoba; S.M. Edworthy, MD, Professor, Division of Rheumatology, University of Calgary; L. Svenson, BSc, Health Surveillance Branch, Public Health Division, Alberta Health and Wellness; C.A. Pineau, MD, Assistant Professor, Division of Rheumatology, Research Institute of the MUHC; A.E. Clarke, MD, MSc, Professor of Medicine, Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Research Institute of the MUHC; M. Smith, MSc, Associate Director, Repository, Manitoba Centre for Health Policy, University of Manitoba; P. Bélisle, MSc, Division of Clinical Epidemiology, Research Institute of the MUHC; E.M. Badley, D.Phil, Professor, Senior Scientist, Toronto Western Research Institute University Health Network; L. Bergeron, Patient advocate, Canadian Arthritis Patient Alliance; S. Bernatsky, MD, PhD, Associate Professor, Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre. Address correspondence to Dr. S. Bernatsky, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre (MUHC), 687 Pine Avenue West, V-Building, V2.09, Montreal, Quebec H3A 1A1, Canada. E-mail: sasha.bernatsky@mcgill.ca. Accepted for publication December 19, 2013.
Marie Hudson
From the Division of Clinical Epidemiology, and Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia; Department of Epidemiology and Biostatistics, and Division of Rheumatology, McGill University; Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Departments of Medicine and Community Health Sciences, University of Manitoba, and Repository, Manitoba Centre for Health Policy, Winnipeg, Manitoba; Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario; Division of Rheumatology, University of Calgary, Calgary, Alberta; Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval, Quebec City, Quebec; Chronic Disease Surveillance Division, National Institute of Public Health of Québec; Health Surveillance Branch, Public Health Division, Alberta Health and Wellness, Edmonton, Alberta; Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the MUHC; Canadian Arthritis Patient Alliance; Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada. L. Broten, Student, Division of Clinical Epidemiology, Research Institute of the MUHC; J.A. Aviña-Zubieta, MD, PhD, BC Lupus Society Scholar, Assistant Professor; D. Lacaille, MD, MHSc, Professor, Division of Rheumatology, University of British Columbia; L. Joseph, PhD, Professor, Department of Epidemiology and Biostatistics, McGill University; J.G. Hanly, MD, Professor of Medicine (Rheumatology) and Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center; L. Lix, PhD, Professor, Department of Community Health Sciences, University of Manitoba; S. O’Donnell, MSc, Centre for Chronic Disease Prevention, Public Health Agency of Canada; C. Barnabe, MD, MSc, Assistant Professor, Division of Rheumatology, University of Calgary; P.R. Fortin, MD, MPH, Professor, Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval; M. Hudson, MD, Assistant Professor, Division of Rheumatology, McGill University; S. Jean, PhD, Chronic Disease Surveillance Division, National Institute of Public Health of Québec; C.A. Peschken, MD, MSc, Associate Professor, Departments of Medicine and Community Health Sciences Director, University of Manitoba; S.M. Edworthy, MD, Professor, Division of Rheumatology, University of Calgary; L. Svenson, BSc, Health Surveillance Branch, Public Health Division, Alberta Health and Wellness; C.A. Pineau, MD, Assistant Professor, Division of Rheumatology, Research Institute of the MUHC; A.E. Clarke, MD, MSc, Professor of Medicine, Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Research Institute of the MUHC; M. Smith, MSc, Associate Director, Repository, Manitoba Centre for Health Policy, University of Manitoba; P. Bélisle, MSc, Division of Clinical Epidemiology, Research Institute of the MUHC; E.M. Badley, D.Phil, Professor, Senior Scientist, Toronto Western Research Institute University Health Network; L. Bergeron, Patient advocate, Canadian Arthritis Patient Alliance; S. Bernatsky, MD, PhD, Associate Professor, Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre. Address correspondence to Dr. S. Bernatsky, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre (MUHC), 687 Pine Avenue West, V-Building, V2.09, Montreal, Quebec H3A 1A1, Canada. E-mail: sasha.bernatsky@mcgill.ca. Accepted for publication December 19, 2013.
Sonia Jean
From the Division of Clinical Epidemiology, and Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia; Department of Epidemiology and Biostatistics, and Division of Rheumatology, McGill University; Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Departments of Medicine and Community Health Sciences, University of Manitoba, and Repository, Manitoba Centre for Health Policy, Winnipeg, Manitoba; Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario; Division of Rheumatology, University of Calgary, Calgary, Alberta; Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval, Quebec City, Quebec; Chronic Disease Surveillance Division, National Institute of Public Health of Québec; Health Surveillance Branch, Public Health Division, Alberta Health and Wellness, Edmonton, Alberta; Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the MUHC; Canadian Arthritis Patient Alliance; Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada. L. Broten, Student, Division of Clinical Epidemiology, Research Institute of the MUHC; J.A. Aviña-Zubieta, MD, PhD, BC Lupus Society Scholar, Assistant Professor; D. Lacaille, MD, MHSc, Professor, Division of Rheumatology, University of British Columbia; L. Joseph, PhD, Professor, Department of Epidemiology and Biostatistics, McGill University; J.G. Hanly, MD, Professor of Medicine (Rheumatology) and Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center; L. Lix, PhD, Professor, Department of Community Health Sciences, University of Manitoba; S. O’Donnell, MSc, Centre for Chronic Disease Prevention, Public Health Agency of Canada; C. Barnabe, MD, MSc, Assistant Professor, Division of Rheumatology, University of Calgary; P.R. Fortin, MD, MPH, Professor, Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval; M. Hudson, MD, Assistant Professor, Division of Rheumatology, McGill University; S. Jean, PhD, Chronic Disease Surveillance Division, National Institute of Public Health of Québec; C.A. Peschken, MD, MSc, Associate Professor, Departments of Medicine and Community Health Sciences Director, University of Manitoba; S.M. Edworthy, MD, Professor, Division of Rheumatology, University of Calgary; L. Svenson, BSc, Health Surveillance Branch, Public Health Division, Alberta Health and Wellness; C.A. Pineau, MD, Assistant Professor, Division of Rheumatology, Research Institute of the MUHC; A.E. Clarke, MD, MSc, Professor of Medicine, Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Research Institute of the MUHC; M. Smith, MSc, Associate Director, Repository, Manitoba Centre for Health Policy, University of Manitoba; P. Bélisle, MSc, Division of Clinical Epidemiology, Research Institute of the MUHC; E.M. Badley, D.Phil, Professor, Senior Scientist, Toronto Western Research Institute University Health Network; L. Bergeron, Patient advocate, Canadian Arthritis Patient Alliance; S. Bernatsky, MD, PhD, Associate Professor, Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre. Address correspondence to Dr. S. Bernatsky, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre (MUHC), 687 Pine Avenue West, V-Building, V2.09, Montreal, Quebec H3A 1A1, Canada. E-mail: sasha.bernatsky@mcgill.ca. Accepted for publication December 19, 2013.
Christine Peschken
From the Division of Clinical Epidemiology, and Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia; Department of Epidemiology and Biostatistics, and Division of Rheumatology, McGill University; Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Departments of Medicine and Community Health Sciences, University of Manitoba, and Repository, Manitoba Centre for Health Policy, Winnipeg, Manitoba; Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario; Division of Rheumatology, University of Calgary, Calgary, Alberta; Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval, Quebec City, Quebec; Chronic Disease Surveillance Division, National Institute of Public Health of Québec; Health Surveillance Branch, Public Health Division, Alberta Health and Wellness, Edmonton, Alberta; Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the MUHC; Canadian Arthritis Patient Alliance; Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada. L. Broten, Student, Division of Clinical Epidemiology, Research Institute of the MUHC; J.A. Aviña-Zubieta, MD, PhD, BC Lupus Society Scholar, Assistant Professor; D. Lacaille, MD, MHSc, Professor, Division of Rheumatology, University of British Columbia; L. Joseph, PhD, Professor, Department of Epidemiology and Biostatistics, McGill University; J.G. Hanly, MD, Professor of Medicine (Rheumatology) and Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center; L. Lix, PhD, Professor, Department of Community Health Sciences, University of Manitoba; S. O’Donnell, MSc, Centre for Chronic Disease Prevention, Public Health Agency of Canada; C. Barnabe, MD, MSc, Assistant Professor, Division of Rheumatology, University of Calgary; P.R. Fortin, MD, MPH, Professor, Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval; M. Hudson, MD, Assistant Professor, Division of Rheumatology, McGill University; S. Jean, PhD, Chronic Disease Surveillance Division, National Institute of Public Health of Québec; C.A. Peschken, MD, MSc, Associate Professor, Departments of Medicine and Community Health Sciences Director, University of Manitoba; S.M. Edworthy, MD, Professor, Division of Rheumatology, University of Calgary; L. Svenson, BSc, Health Surveillance Branch, Public Health Division, Alberta Health and Wellness; C.A. Pineau, MD, Assistant Professor, Division of Rheumatology, Research Institute of the MUHC; A.E. Clarke, MD, MSc, Professor of Medicine, Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Research Institute of the MUHC; M. Smith, MSc, Associate Director, Repository, Manitoba Centre for Health Policy, University of Manitoba; P. Bélisle, MSc, Division of Clinical Epidemiology, Research Institute of the MUHC; E.M. Badley, D.Phil, Professor, Senior Scientist, Toronto Western Research Institute University Health Network; L. Bergeron, Patient advocate, Canadian Arthritis Patient Alliance; S. Bernatsky, MD, PhD, Associate Professor, Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre. Address correspondence to Dr. S. Bernatsky, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre (MUHC), 687 Pine Avenue West, V-Building, V2.09, Montreal, Quebec H3A 1A1, Canada. E-mail: sasha.bernatsky@mcgill.ca. Accepted for publication December 19, 2013.
Steven M. Edworthy
From the Division of Clinical Epidemiology, and Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia; Department of Epidemiology and Biostatistics, and Division of Rheumatology, McGill University; Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Departments of Medicine and Community Health Sciences, University of Manitoba, and Repository, Manitoba Centre for Health Policy, Winnipeg, Manitoba; Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario; Division of Rheumatology, University of Calgary, Calgary, Alberta; Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval, Quebec City, Quebec; Chronic Disease Surveillance Division, National Institute of Public Health of Québec; Health Surveillance Branch, Public Health Division, Alberta Health and Wellness, Edmonton, Alberta; Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the MUHC; Canadian Arthritis Patient Alliance; Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada. L. Broten, Student, Division of Clinical Epidemiology, Research Institute of the MUHC; J.A. Aviña-Zubieta, MD, PhD, BC Lupus Society Scholar, Assistant Professor; D. Lacaille, MD, MHSc, Professor, Division of Rheumatology, University of British Columbia; L. Joseph, PhD, Professor, Department of Epidemiology and Biostatistics, McGill University; J.G. Hanly, MD, Professor of Medicine (Rheumatology) and Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center; L. Lix, PhD, Professor, Department of Community Health Sciences, University of Manitoba; S. O’Donnell, MSc, Centre for Chronic Disease Prevention, Public Health Agency of Canada; C. Barnabe, MD, MSc, Assistant Professor, Division of Rheumatology, University of Calgary; P.R. Fortin, MD, MPH, Professor, Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval; M. Hudson, MD, Assistant Professor, Division of Rheumatology, McGill University; S. Jean, PhD, Chronic Disease Surveillance Division, National Institute of Public Health of Québec; C.A. Peschken, MD, MSc, Associate Professor, Departments of Medicine and Community Health Sciences Director, University of Manitoba; S.M. Edworthy, MD, Professor, Division of Rheumatology, University of Calgary; L. Svenson, BSc, Health Surveillance Branch, Public Health Division, Alberta Health and Wellness; C.A. Pineau, MD, Assistant Professor, Division of Rheumatology, Research Institute of the MUHC; A.E. Clarke, MD, MSc, Professor of Medicine, Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Research Institute of the MUHC; M. Smith, MSc, Associate Director, Repository, Manitoba Centre for Health Policy, University of Manitoba; P. Bélisle, MSc, Division of Clinical Epidemiology, Research Institute of the MUHC; E.M. Badley, D.Phil, Professor, Senior Scientist, Toronto Western Research Institute University Health Network; L. Bergeron, Patient advocate, Canadian Arthritis Patient Alliance; S. Bernatsky, MD, PhD, Associate Professor, Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre. Address correspondence to Dr. S. Bernatsky, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre (MUHC), 687 Pine Avenue West, V-Building, V2.09, Montreal, Quebec H3A 1A1, Canada. E-mail: sasha.bernatsky@mcgill.ca. Accepted for publication December 19, 2013.
Larry Svenson
From the Division of Clinical Epidemiology, and Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia; Department of Epidemiology and Biostatistics, and Division of Rheumatology, McGill University; Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Departments of Medicine and Community Health Sciences, University of Manitoba, and Repository, Manitoba Centre for Health Policy, Winnipeg, Manitoba; Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario; Division of Rheumatology, University of Calgary, Calgary, Alberta; Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval, Quebec City, Quebec; Chronic Disease Surveillance Division, National Institute of Public Health of Québec; Health Surveillance Branch, Public Health Division, Alberta Health and Wellness, Edmonton, Alberta; Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the MUHC; Canadian Arthritis Patient Alliance; Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada. L. Broten, Student, Division of Clinical Epidemiology, Research Institute of the MUHC; J.A. Aviña-Zubieta, MD, PhD, BC Lupus Society Scholar, Assistant Professor; D. Lacaille, MD, MHSc, Professor, Division of Rheumatology, University of British Columbia; L. Joseph, PhD, Professor, Department of Epidemiology and Biostatistics, McGill University; J.G. Hanly, MD, Professor of Medicine (Rheumatology) and Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center; L. Lix, PhD, Professor, Department of Community Health Sciences, University of Manitoba; S. O’Donnell, MSc, Centre for Chronic Disease Prevention, Public Health Agency of Canada; C. Barnabe, MD, MSc, Assistant Professor, Division of Rheumatology, University of Calgary; P.R. Fortin, MD, MPH, Professor, Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval; M. Hudson, MD, Assistant Professor, Division of Rheumatology, McGill University; S. Jean, PhD, Chronic Disease Surveillance Division, National Institute of Public Health of Québec; C.A. Peschken, MD, MSc, Associate Professor, Departments of Medicine and Community Health Sciences Director, University of Manitoba; S.M. Edworthy, MD, Professor, Division of Rheumatology, University of Calgary; L. Svenson, BSc, Health Surveillance Branch, Public Health Division, Alberta Health and Wellness; C.A. Pineau, MD, Assistant Professor, Division of Rheumatology, Research Institute of the MUHC; A.E. Clarke, MD, MSc, Professor of Medicine, Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Research Institute of the MUHC; M. Smith, MSc, Associate Director, Repository, Manitoba Centre for Health Policy, University of Manitoba; P. Bélisle, MSc, Division of Clinical Epidemiology, Research Institute of the MUHC; E.M. Badley, D.Phil, Professor, Senior Scientist, Toronto Western Research Institute University Health Network; L. Bergeron, Patient advocate, Canadian Arthritis Patient Alliance; S. Bernatsky, MD, PhD, Associate Professor, Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre. Address correspondence to Dr. S. Bernatsky, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre (MUHC), 687 Pine Avenue West, V-Building, V2.09, Montreal, Quebec H3A 1A1, Canada. E-mail: sasha.bernatsky@mcgill.ca. Accepted for publication December 19, 2013.
Christian A. Pineau
From the Division of Clinical Epidemiology, and Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia; Department of Epidemiology and Biostatistics, and Division of Rheumatology, McGill University; Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Departments of Medicine and Community Health Sciences, University of Manitoba, and Repository, Manitoba Centre for Health Policy, Winnipeg, Manitoba; Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario; Division of Rheumatology, University of Calgary, Calgary, Alberta; Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval, Quebec City, Quebec; Chronic Disease Surveillance Division, National Institute of Public Health of Québec; Health Surveillance Branch, Public Health Division, Alberta Health and Wellness, Edmonton, Alberta; Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the MUHC; Canadian Arthritis Patient Alliance; Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada. L. Broten, Student, Division of Clinical Epidemiology, Research Institute of the MUHC; J.A. Aviña-Zubieta, MD, PhD, BC Lupus Society Scholar, Assistant Professor; D. Lacaille, MD, MHSc, Professor, Division of Rheumatology, University of British Columbia; L. Joseph, PhD, Professor, Department of Epidemiology and Biostatistics, McGill University; J.G. Hanly, MD, Professor of Medicine (Rheumatology) and Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center; L. Lix, PhD, Professor, Department of Community Health Sciences, University of Manitoba; S. O’Donnell, MSc, Centre for Chronic Disease Prevention, Public Health Agency of Canada; C. Barnabe, MD, MSc, Assistant Professor, Division of Rheumatology, University of Calgary; P.R. Fortin, MD, MPH, Professor, Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval; M. Hudson, MD, Assistant Professor, Division of Rheumatology, McGill University; S. Jean, PhD, Chronic Disease Surveillance Division, National Institute of Public Health of Québec; C.A. Peschken, MD, MSc, Associate Professor, Departments of Medicine and Community Health Sciences Director, University of Manitoba; S.M. Edworthy, MD, Professor, Division of Rheumatology, University of Calgary; L. Svenson, BSc, Health Surveillance Branch, Public Health Division, Alberta Health and Wellness; C.A. Pineau, MD, Assistant Professor, Division of Rheumatology, Research Institute of the MUHC; A.E. Clarke, MD, MSc, Professor of Medicine, Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Research Institute of the MUHC; M. Smith, MSc, Associate Director, Repository, Manitoba Centre for Health Policy, University of Manitoba; P. Bélisle, MSc, Division of Clinical Epidemiology, Research Institute of the MUHC; E.M. Badley, D.Phil, Professor, Senior Scientist, Toronto Western Research Institute University Health Network; L. Bergeron, Patient advocate, Canadian Arthritis Patient Alliance; S. Bernatsky, MD, PhD, Associate Professor, Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre. Address correspondence to Dr. S. Bernatsky, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre (MUHC), 687 Pine Avenue West, V-Building, V2.09, Montreal, Quebec H3A 1A1, Canada. E-mail: sasha.bernatsky@mcgill.ca. Accepted for publication December 19, 2013.
Ann E. Clarke
From the Division of Clinical Epidemiology, and Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia; Department of Epidemiology and Biostatistics, and Division of Rheumatology, McGill University; Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Departments of Medicine and Community Health Sciences, University of Manitoba, and Repository, Manitoba Centre for Health Policy, Winnipeg, Manitoba; Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario; Division of Rheumatology, University of Calgary, Calgary, Alberta; Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval, Quebec City, Quebec; Chronic Disease Surveillance Division, National Institute of Public Health of Québec; Health Surveillance Branch, Public Health Division, Alberta Health and Wellness, Edmonton, Alberta; Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the MUHC; Canadian Arthritis Patient Alliance; Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada. L. Broten, Student, Division of Clinical Epidemiology, Research Institute of the MUHC; J.A. Aviña-Zubieta, MD, PhD, BC Lupus Society Scholar, Assistant Professor; D. Lacaille, MD, MHSc, Professor, Division of Rheumatology, University of British Columbia; L. Joseph, PhD, Professor, Department of Epidemiology and Biostatistics, McGill University; J.G. Hanly, MD, Professor of Medicine (Rheumatology) and Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center; L. Lix, PhD, Professor, Department of Community Health Sciences, University of Manitoba; S. O’Donnell, MSc, Centre for Chronic Disease Prevention, Public Health Agency of Canada; C. Barnabe, MD, MSc, Assistant Professor, Division of Rheumatology, University of Calgary; P.R. Fortin, MD, MPH, Professor, Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval; M. Hudson, MD, Assistant Professor, Division of Rheumatology, McGill University; S. Jean, PhD, Chronic Disease Surveillance Division, National Institute of Public Health of Québec; C.A. Peschken, MD, MSc, Associate Professor, Departments of Medicine and Community Health Sciences Director, University of Manitoba; S.M. Edworthy, MD, Professor, Division of Rheumatology, University of Calgary; L. Svenson, BSc, Health Surveillance Branch, Public Health Division, Alberta Health and Wellness; C.A. Pineau, MD, Assistant Professor, Division of Rheumatology, Research Institute of the MUHC; A.E. Clarke, MD, MSc, Professor of Medicine, Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Research Institute of the MUHC; M. Smith, MSc, Associate Director, Repository, Manitoba Centre for Health Policy, University of Manitoba; P. Bélisle, MSc, Division of Clinical Epidemiology, Research Institute of the MUHC; E.M. Badley, D.Phil, Professor, Senior Scientist, Toronto Western Research Institute University Health Network; L. Bergeron, Patient advocate, Canadian Arthritis Patient Alliance; S. Bernatsky, MD, PhD, Associate Professor, Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre. Address correspondence to Dr. S. Bernatsky, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre (MUHC), 687 Pine Avenue West, V-Building, V2.09, Montreal, Quebec H3A 1A1, Canada. E-mail: sasha.bernatsky@mcgill.ca. Accepted for publication December 19, 2013.
Mark Smith
From the Division of Clinical Epidemiology, and Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia; Department of Epidemiology and Biostatistics, and Division of Rheumatology, McGill University; Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Departments of Medicine and Community Health Sciences, University of Manitoba, and Repository, Manitoba Centre for Health Policy, Winnipeg, Manitoba; Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario; Division of Rheumatology, University of Calgary, Calgary, Alberta; Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval, Quebec City, Quebec; Chronic Disease Surveillance Division, National Institute of Public Health of Québec; Health Surveillance Branch, Public Health Division, Alberta Health and Wellness, Edmonton, Alberta; Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the MUHC; Canadian Arthritis Patient Alliance; Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada. L. Broten, Student, Division of Clinical Epidemiology, Research Institute of the MUHC; J.A. Aviña-Zubieta, MD, PhD, BC Lupus Society Scholar, Assistant Professor; D. Lacaille, MD, MHSc, Professor, Division of Rheumatology, University of British Columbia; L. Joseph, PhD, Professor, Department of Epidemiology and Biostatistics, McGill University; J.G. Hanly, MD, Professor of Medicine (Rheumatology) and Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center; L. Lix, PhD, Professor, Department of Community Health Sciences, University of Manitoba; S. O’Donnell, MSc, Centre for Chronic Disease Prevention, Public Health Agency of Canada; C. Barnabe, MD, MSc, Assistant Professor, Division of Rheumatology, University of Calgary; P.R. Fortin, MD, MPH, Professor, Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval; M. Hudson, MD, Assistant Professor, Division of Rheumatology, McGill University; S. Jean, PhD, Chronic Disease Surveillance Division, National Institute of Public Health of Québec; C.A. Peschken, MD, MSc, Associate Professor, Departments of Medicine and Community Health Sciences Director, University of Manitoba; S.M. Edworthy, MD, Professor, Division of Rheumatology, University of Calgary; L. Svenson, BSc, Health Surveillance Branch, Public Health Division, Alberta Health and Wellness; C.A. Pineau, MD, Assistant Professor, Division of Rheumatology, Research Institute of the MUHC; A.E. Clarke, MD, MSc, Professor of Medicine, Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Research Institute of the MUHC; M. Smith, MSc, Associate Director, Repository, Manitoba Centre for Health Policy, University of Manitoba; P. Bélisle, MSc, Division of Clinical Epidemiology, Research Institute of the MUHC; E.M. Badley, D.Phil, Professor, Senior Scientist, Toronto Western Research Institute University Health Network; L. Bergeron, Patient advocate, Canadian Arthritis Patient Alliance; S. Bernatsky, MD, PhD, Associate Professor, Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre. Address correspondence to Dr. S. Bernatsky, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre (MUHC), 687 Pine Avenue West, V-Building, V2.09, Montreal, Quebec H3A 1A1, Canada. E-mail: sasha.bernatsky@mcgill.ca. Accepted for publication December 19, 2013.
Patrick Bélisle
From the Division of Clinical Epidemiology, and Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia; Department of Epidemiology and Biostatistics, and Division of Rheumatology, McGill University; Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Departments of Medicine and Community Health Sciences, University of Manitoba, and Repository, Manitoba Centre for Health Policy, Winnipeg, Manitoba; Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario; Division of Rheumatology, University of Calgary, Calgary, Alberta; Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval, Quebec City, Quebec; Chronic Disease Surveillance Division, National Institute of Public Health of Québec; Health Surveillance Branch, Public Health Division, Alberta Health and Wellness, Edmonton, Alberta; Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the MUHC; Canadian Arthritis Patient Alliance; Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada. L. Broten, Student, Division of Clinical Epidemiology, Research Institute of the MUHC; J.A. Aviña-Zubieta, MD, PhD, BC Lupus Society Scholar, Assistant Professor; D. Lacaille, MD, MHSc, Professor, Division of Rheumatology, University of British Columbia; L. Joseph, PhD, Professor, Department of Epidemiology and Biostatistics, McGill University; J.G. Hanly, MD, Professor of Medicine (Rheumatology) and Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center; L. Lix, PhD, Professor, Department of Community Health Sciences, University of Manitoba; S. O’Donnell, MSc, Centre for Chronic Disease Prevention, Public Health Agency of Canada; C. Barnabe, MD, MSc, Assistant Professor, Division of Rheumatology, University of Calgary; P.R. Fortin, MD, MPH, Professor, Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval; M. Hudson, MD, Assistant Professor, Division of Rheumatology, McGill University; S. Jean, PhD, Chronic Disease Surveillance Division, National Institute of Public Health of Québec; C.A. Peschken, MD, MSc, Associate Professor, Departments of Medicine and Community Health Sciences Director, University of Manitoba; S.M. Edworthy, MD, Professor, Division of Rheumatology, University of Calgary; L. Svenson, BSc, Health Surveillance Branch, Public Health Division, Alberta Health and Wellness; C.A. Pineau, MD, Assistant Professor, Division of Rheumatology, Research Institute of the MUHC; A.E. Clarke, MD, MSc, Professor of Medicine, Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Research Institute of the MUHC; M. Smith, MSc, Associate Director, Repository, Manitoba Centre for Health Policy, University of Manitoba; P. Bélisle, MSc, Division of Clinical Epidemiology, Research Institute of the MUHC; E.M. Badley, D.Phil, Professor, Senior Scientist, Toronto Western Research Institute University Health Network; L. Bergeron, Patient advocate, Canadian Arthritis Patient Alliance; S. Bernatsky, MD, PhD, Associate Professor, Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre. Address correspondence to Dr. S. Bernatsky, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre (MUHC), 687 Pine Avenue West, V-Building, V2.09, Montreal, Quebec H3A 1A1, Canada. E-mail: sasha.bernatsky@mcgill.ca. Accepted for publication December 19, 2013.
Elizabeth M. Badley
From the Division of Clinical Epidemiology, and Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia; Department of Epidemiology and Biostatistics, and Division of Rheumatology, McGill University; Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Departments of Medicine and Community Health Sciences, University of Manitoba, and Repository, Manitoba Centre for Health Policy, Winnipeg, Manitoba; Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario; Division of Rheumatology, University of Calgary, Calgary, Alberta; Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval, Quebec City, Quebec; Chronic Disease Surveillance Division, National Institute of Public Health of Québec; Health Surveillance Branch, Public Health Division, Alberta Health and Wellness, Edmonton, Alberta; Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the MUHC; Canadian Arthritis Patient Alliance; Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada. L. Broten, Student, Division of Clinical Epidemiology, Research Institute of the MUHC; J.A. Aviña-Zubieta, MD, PhD, BC Lupus Society Scholar, Assistant Professor; D. Lacaille, MD, MHSc, Professor, Division of Rheumatology, University of British Columbia; L. Joseph, PhD, Professor, Department of Epidemiology and Biostatistics, McGill University; J.G. Hanly, MD, Professor of Medicine (Rheumatology) and Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center; L. Lix, PhD, Professor, Department of Community Health Sciences, University of Manitoba; S. O’Donnell, MSc, Centre for Chronic Disease Prevention, Public Health Agency of Canada; C. Barnabe, MD, MSc, Assistant Professor, Division of Rheumatology, University of Calgary; P.R. Fortin, MD, MPH, Professor, Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval; M. Hudson, MD, Assistant Professor, Division of Rheumatology, McGill University; S. Jean, PhD, Chronic Disease Surveillance Division, National Institute of Public Health of Québec; C.A. Peschken, MD, MSc, Associate Professor, Departments of Medicine and Community Health Sciences Director, University of Manitoba; S.M. Edworthy, MD, Professor, Division of Rheumatology, University of Calgary; L. Svenson, BSc, Health Surveillance Branch, Public Health Division, Alberta Health and Wellness; C.A. Pineau, MD, Assistant Professor, Division of Rheumatology, Research Institute of the MUHC; A.E. Clarke, MD, MSc, Professor of Medicine, Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Research Institute of the MUHC; M. Smith, MSc, Associate Director, Repository, Manitoba Centre for Health Policy, University of Manitoba; P. Bélisle, MSc, Division of Clinical Epidemiology, Research Institute of the MUHC; E.M. Badley, D.Phil, Professor, Senior Scientist, Toronto Western Research Institute University Health Network; L. Bergeron, Patient advocate, Canadian Arthritis Patient Alliance; S. Bernatsky, MD, PhD, Associate Professor, Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre. Address correspondence to Dr. S. Bernatsky, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre (MUHC), 687 Pine Avenue West, V-Building, V2.09, Montreal, Quebec H3A 1A1, Canada. E-mail: sasha.bernatsky@mcgill.ca. Accepted for publication December 19, 2013.
Louise Bergeron
From the Division of Clinical Epidemiology, and Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia; Department of Epidemiology and Biostatistics, and Division of Rheumatology, McGill University; Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Departments of Medicine and Community Health Sciences, University of Manitoba, and Repository, Manitoba Centre for Health Policy, Winnipeg, Manitoba; Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario; Division of Rheumatology, University of Calgary, Calgary, Alberta; Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval, Quebec City, Quebec; Chronic Disease Surveillance Division, National Institute of Public Health of Québec; Health Surveillance Branch, Public Health Division, Alberta Health and Wellness, Edmonton, Alberta; Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the MUHC; Canadian Arthritis Patient Alliance; Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada. L. Broten, Student, Division of Clinical Epidemiology, Research Institute of the MUHC; J.A. Aviña-Zubieta, MD, PhD, BC Lupus Society Scholar, Assistant Professor; D. Lacaille, MD, MHSc, Professor, Division of Rheumatology, University of British Columbia; L. Joseph, PhD, Professor, Department of Epidemiology and Biostatistics, McGill University; J.G. Hanly, MD, Professor of Medicine (Rheumatology) and Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center; L. Lix, PhD, Professor, Department of Community Health Sciences, University of Manitoba; S. O’Donnell, MSc, Centre for Chronic Disease Prevention, Public Health Agency of Canada; C. Barnabe, MD, MSc, Assistant Professor, Division of Rheumatology, University of Calgary; P.R. Fortin, MD, MPH, Professor, Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval; M. Hudson, MD, Assistant Professor, Division of Rheumatology, McGill University; S. Jean, PhD, Chronic Disease Surveillance Division, National Institute of Public Health of Québec; C.A. Peschken, MD, MSc, Associate Professor, Departments of Medicine and Community Health Sciences Director, University of Manitoba; S.M. Edworthy, MD, Professor, Division of Rheumatology, University of Calgary; L. Svenson, BSc, Health Surveillance Branch, Public Health Division, Alberta Health and Wellness; C.A. Pineau, MD, Assistant Professor, Division of Rheumatology, Research Institute of the MUHC; A.E. Clarke, MD, MSc, Professor of Medicine, Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Research Institute of the MUHC; M. Smith, MSc, Associate Director, Repository, Manitoba Centre for Health Policy, University of Manitoba; P. Bélisle, MSc, Division of Clinical Epidemiology, Research Institute of the MUHC; E.M. Badley, D.Phil, Professor, Senior Scientist, Toronto Western Research Institute University Health Network; L. Bergeron, Patient advocate, Canadian Arthritis Patient Alliance; S. Bernatsky, MD, PhD, Associate Professor, Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre. Address correspondence to Dr. S. Bernatsky, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre (MUHC), 687 Pine Avenue West, V-Building, V2.09, Montreal, Quebec H3A 1A1, Canada. E-mail: sasha.bernatsky@mcgill.ca. Accepted for publication December 19, 2013.
Sasha Bernatsky
From the Division of Clinical Epidemiology, and Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia; Department of Epidemiology and Biostatistics, and Division of Rheumatology, McGill University; Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Departments of Medicine and Community Health Sciences, University of Manitoba, and Repository, Manitoba Centre for Health Policy, Winnipeg, Manitoba; Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario; Division of Rheumatology, University of Calgary, Calgary, Alberta; Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval, Quebec City, Quebec; Chronic Disease Surveillance Division, National Institute of Public Health of Québec; Health Surveillance Branch, Public Health Division, Alberta Health and Wellness, Edmonton, Alberta; Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the MUHC; Canadian Arthritis Patient Alliance; Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada. L. Broten, Student, Division of Clinical Epidemiology, Research Institute of the MUHC; J.A. Aviña-Zubieta, MD, PhD, BC Lupus Society Scholar, Assistant Professor; D. Lacaille, MD, MHSc, Professor, Division of Rheumatology, University of British Columbia; L. Joseph, PhD, Professor, Department of Epidemiology and Biostatistics, McGill University; J.G. Hanly, MD, Professor of Medicine (Rheumatology) and Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center; L. Lix, PhD, Professor, Department of Community Health Sciences, University of Manitoba; S. O’Donnell, MSc, Centre for Chronic Disease Prevention, Public Health Agency of Canada; C. Barnabe, MD, MSc, Assistant Professor, Division of Rheumatology, University of Calgary; P.R. Fortin, MD, MPH, Professor, Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval; M. Hudson, MD, Assistant Professor, Division of Rheumatology, McGill University; S. Jean, PhD, Chronic Disease Surveillance Division, National Institute of Public Health of Québec; C.A. Peschken, MD, MSc, Associate Professor, Departments of Medicine and Community Health Sciences Director, University of Manitoba; S.M. Edworthy, MD, Professor, Division of Rheumatology, University of Calgary; L. Svenson, BSc, Health Surveillance Branch, Public Health Division, Alberta Health and Wellness; C.A. Pineau, MD, Assistant Professor, Division of Rheumatology, Research Institute of the MUHC; A.E. Clarke, MD, MSc, Professor of Medicine, Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Research Institute of the MUHC; M. Smith, MSc, Associate Director, Repository, Manitoba Centre for Health Policy, University of Manitoba; P. Bélisle, MSc, Division of Clinical Epidemiology, Research Institute of the MUHC; E.M. Badley, D.Phil, Professor, Senior Scientist, Toronto Western Research Institute University Health Network; L. Bergeron, Patient advocate, Canadian Arthritis Patient Alliance; S. Bernatsky, MD, PhD, Associate Professor, Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre. Address correspondence to Dr. S. Bernatsky, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre (MUHC), 687 Pine Avenue West, V-Building, V2.09, Montreal, Quebec H3A 1A1, Canada. E-mail: sasha.bernatsky@mcgill.ca. Accepted for publication December 19, 2013.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Systemic Autoimmune Rheumatic Disease Prevalence in Canada: Updated Analyses Across 7 Provinces
Laurel Broten, J. Antonio Aviña-Zubieta, Diane Lacaille, Lawrence Joseph, John G. Hanly, Lisa Lix, Siobhan O’Donnell, Cheryl Barnabe, Paul R. Fortin, Marie Hudson, Sonia Jean, Christine Peschken, Steven M. Edworthy, Larry Svenson, Christian A. Pineau, Ann E. Clarke, Mark Smith, Patrick Bélisle, Elizabeth M. Badley, Louise Bergeron, Sasha Bernatsky
The Journal of Rheumatology Mar 2014, jrheum.130667; DOI: 10.3899/jrheum.130667
Systemic Autoimmune Rheumatic Disease Prevalence in Canada: Updated Analyses Across 7 Provinces
Laurel Broten, J. Antonio Aviña-Zubieta, Diane Lacaille, Lawrence Joseph, John G. Hanly, Lisa Lix, Siobhan O’Donnell, Cheryl Barnabe, Paul R. Fortin, Marie Hudson, Sonia Jean, Christine Peschken, Steven M. Edworthy, Larry Svenson, Christian A. Pineau, Ann E. Clarke, Mark Smith, Patrick Bélisle, Elizabeth M. Badley, Louise Bergeron, Sasha Bernatsky
The Journal of Rheumatology Mar 2014, jrheum.130667; DOI: 10.3899/jrheum.130667